Evidence map›Paper›PMID 24021712›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Hepatitis B virus in the State of Alagoas, Brazil: genotypes characterization and mutations of the precore and basal core promoter regions.

Alba Maria Xavier Eloy, Regina Célia Moreira, Marcílio Figueiredo Lemos, Jéfferson Luis de Almeida Silva, Maria Rosângela Cunha Duarte Coêlho

Abstract read
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alba Maria Xavier EloyInstitute of Biological and Health Sciences (ICBS), Universidade Federal de Alagoas (UFAL), Maceió, AL, Brazil; Clinical Analysis Laboratory, Prof. Alberto Antunes University Hospital, UFAL, Maceió, AL, Brazil.
Regina Célia Moreira
Marcílio Figueiredo Lemos
Jéfferson Luis de Almeida Silva
Maria Rosângela Cunha Duarte Coêlho

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this study were to investigate the genotypes of hepatitis B virus and to identify the precore G1896A and basal core promoter A1762T/G1764A mutations in HBsAg and anti-HBc-positive patients. Eighty-three asymptomatic individuals, three with acute hepatitis B and 33 with chronic hepatitis B referred to viral hepatitis centers in the State of Alagoas, Brazil were analyzed according to their viral load, HBeAg/anti-HBe profile and alanine aminotransferase serum level. The genotypes identified were: A (92.5%), C (5%), D (1.25%) and F (1.25%). The precore mutation was detected in 3.8% of sequences and basal core promoter mutation in 52.4%. These were identified in 45.45% of the asymptomatic individuals and 54.55% of the patients with chronic hepatitis, irrespective of viral load and alanine aminotransferase serum level. In genotype C, only the basal core promoter mutation was identified and no mutations were identified in genotypes D and F.

Indexed as

Acute DiseaseAdultAlanine TransaminaseBrazilDNA, ViralGenotypeHepatitis BHepatitis B AntibodiesHepatitis B, ChronicHepatitis B Core AntigensHepatitis B e AntigensHepatitis B virusHumansMutationPolymerase Chain ReactionPromoter Regions, GeneticAlanine TransaminaseDNA, ViralHepatitis B AntibodiesHepatitis B Core AntigensHepatitis B e AntigensViral Core ProteinsAlagoasBrazilGenotypesHBV mutation

Identifiers

PMID24021712
PMCPMC9427428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.